Complex renal cysts (Bosniak ≥IIF):Interobserver agreement, Progression and Malignancy rates by Lucocq, James et al.
                                                                    
University of Dundee
Complex renal cysts (Bosniak IIF)








Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Lucocq, J., Pillai, S., Oparka, R., & Nabi, G. (2021). Complex renal cysts (Bosniak IIF): Interobserver agreement,
Progression and Malignancy rates. European Radiology, 31, 901-908. https://doi.org/10.1007/s00330-020-
07186-w
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 27. Apr. 2021
UROGENITAL
Complex renal cysts (Bosniak ≥IIF): interobserver
agreement, progression and malignancy rates
James Lucocq1 & Sanjay Pillai2 & Richard Oparka3 & Ghulam Nabi1
Received: 8 May 2020 /Revised: 25 June 2020 /Accepted: 12 August 2020
# The Author(s) 2020
Abstract
Objective The objective was to assess the interobserver agreement rate, progression rates and malignancy rates in the assessment
of complex renal cysts (≥ Bosniak IIF) using a population-based database.
Methods A regional database identified 452 complex renal cysts in 415 patients between 2009 and 2019. Each patient was
tracked and followed up using a unique identifier and deterministic linkage methodology. The interobserver agreement rate
between radiologists was calculated using a weighted kappa statistic. Progression and malignancy rates of cysts (Bosniak ≥IIF)
over the 11-year period were calculated.
Results The linear-weighted kappa value was 0.69 for all complex cysts. The rate of progression and regression of Bosniak IIF
cysts was 4.6% (7/151) and 3.3% (5/151), respectively. All malignant IIF cysts progressed within 16 months of diagnosis. The
malignancy rate of surgically resected Bosniak III and IV cysts was 79.3% (23/29) and 84.5% (39/46), respectively. Of all
malignant tumours, 73.8% and 93.7% were of low ISUP grade and low stage, respectively.
Conclusions This study further confirms that there is a good degree of agreement between radiologists in classifying complex
renal masses using the Bosniak classification. The progression rate of Bosniak IIF cysts is low, but the malignancy rates of
surgically resected Bosniak IIF, III and IV cysts are high. Benign cysts are frequently resected, and a very high proportion of
histopathologically confirmed cancers in complex renal cysts are of low grade and stage.
Key Points
• There is a good degree of agreement between radiologists in classifying complex renal masses using the Bosniak classification.
• The rate of progression of Bosniak IIF cysts is low, and malignant cysts progress early during surveillance. Although the
malignancy rates of resected Bosniak IIF, III and IV cysts are high, the rate of benign cyst resection is significant.
Keywords Neoplasms . Kidney . Cysts
Abbreviation
ISUP International Society of Urological Pathology
Introduction
The Bosniak classification stratifies renal cysts using radio-
logical appearances to determine malignancy risk.
Radiological features indicative of malignancy include irreg-
ular septa, nodular changes, wall thickening and significant
enhancement. Categorising renal cysts accurately using the
Bosniak classification can be challenging due to its subjective
criteria and variations in observer experience [1, 2].Within the
literature, there remains a large degree of variation in the re-
ported interobserver agreement rate between radiologists.
Consequently, the risk of cyst misclassification and
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inappropriate surgical or conservative management is unclear
and warrants further investigation [3, 4].
The management of Bosniak cysts is dependent on cyst
category. Grounded by malignancy rates, the literature sup-
ports discharge of Bosniak I and II cysts, imaging follow-up of
Bosniak IIF cysts and surgical intervention for Bosniak III and
IV cysts. Interval imaging follow-up of Bosniak IIF cysts is
necessary because of the risk of cyst progression and malig-
nancy [5–7]. Although the rate of progression is variable, a
highmalignancy rate of progressed Bosniak IIF cysts has been
reported necessitating follow-up [5, 8]. The likelihood and
time to progression are undetermined in the literature, but a
minimum of 1 year for uncomplicated and up to 4 years for
more complex Bosniak IIF cysts has been suggested [1, 9].
Further studies are required to establish the rate of progres-
sion, rate of malignancy and appropriate length of follow-up.
The malignancy risk of resected Bosniak III cysts is highly
variable in the literature and is reported to be between 33 and
84%; thus, benign cysts are frequently resected unnecessarily
[8, 10–12]. When classified as malignant by histopathology,
Bosniak III cysts are frequently low ISUP grade and stage [7,
13, 14]. Although resection of Bosniak III cysts is advised for
most patients, additional research, in particular with longer
follow-up, is required to establish the rate of benign cyst re-
section and the frequency of low-grade/stage tumours in order
to improve surgical decision-making.
The objectives of this study were:
& To assess the interobserver agreement rate between radi-
ologists to evaluate the reliability of the Bosniak classifi-
cation system and the risk of inappropriate management.
& To evaluate the progression rate of Bosniak IIF cysts and
establish an appropriate length for follow-up of Bosniak
IIF cysts.
& To determine the malignancy rate of resected complex
cysts (Bosniak ≥IIF), particularly Bosniak III cysts.
Methods
Definition of population cohort
A regional database stores the health records of patients with
complex renal cysts diagnosed in a defined geographical area
with a population of more than 416,090 people, based on mid-
year 2017 population estimates [15]. The stable population
with less than 1% migration rate within the area is registered
with the health board through a unique 10-digit identifier
called a Community Health Index (CHI) number. This is a
further update to our previous publication, where the process
of cohort identification has been described [7]. Briefly, all
patients with renal cysts diagnosed between January 2009
and December 2019 were recorded in the regional database
and reviewed at multidisciplinary meetings. The discussions
were recorded on a proforma (Appendix 1), and patients were
followed up with interval imaging as necessary. Following
consensus at multidisciplinary meetings, category I and II
cysts were discharged and the remaining were followed up.
In the case of radiological progression, further discussions in
multidisciplinary meetings were arranged and treatment plans
recorded. For the purposes of investigating complex cysts,
Bosniak I and II cysts, haemorrhagic cysts, inflammatory
cysts and small renal masses (SRMs) were excluded from
analysis. Figure 1 illustrates the study design.
Data collection
The data from each patient with renal cysts were documented
on a secure electronic database and linked to other electronic
databases using a unique 10-digit Community Health Index
(CHI) number. The databases linked using the CHI number
included the National Picture Archiving and Communication
System (PACS), Clinical Portal, Integrated Clinical
Environment (ICE), Referral Management System (RMS)
and Electronic Discharges from hospital systems.
The deterministic records-linkage methodology between
systems provided us with the time to follow-up, time to pro-
gression/regression, details of surgical intervention and the
data of the resected specimen such as histologic subtype,
grade and stage.
Imaging protocol
There is an established protocol to characterise cysts at our
institution as described before [7]. The CT renal characterisa-
tion scan is triphasic with precontrast, arterial (40 s post-
contrast) and nephrographic phases (100 s post-contrast) fol-
lowing IV administration of 100 ml of iodine-based contrast
agent (Omnipaque) and acquired as a volume using a 64-slice
thickness CT scanner (Fig. 2). The 100-s delay helps to visu-
alise the kidneys in their nephrographic phase, the optimal
phase to characterise renal cysts. The nephrographic phase
was also obtained using MRI and gadolinium contrast. T2
HASTE (6-mm slice thickness, 1.8-mm gap), T1 VIBE pre-
and post-contrast (3.5-mm slice thickness, 0.7-mm gap), STIR
(8-mm slice thickness, 2.4-mm gap) and diffusion-weighted
(4-mm slice thickness, 1.2-mm gap; b values 50, 400, 1000
s/mm2) images were obtained. The change in cyst enhance-
ment was measured by calculating the difference in pre- and
post-contrast enhancement.
Follow-up protocol
Patients with Bosniak IIF cysts were followed up in accor-
dance with the local protocol with serial imaging at 6, 12,
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Fig. 1 Study design
Fig. 2 Post-contrast axial CT
images of complex left renal
cysts. a Bosniak IIF cyst
progressing to (b) Bosniak IV
after 6 months with progressing
enhancing wall (arrows), clear
cell carcinoma, pT1a grade 2. c
Bosniak III cyst with thick
enhancing septae (arrow), clear
cell carcinoma, pt1a grade 1. d
Bosniak IV cyst with thick septa
(arrow), clear cell carcinoma,
pT1b grade 2
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24, 36 and 48 months, preferably using the same imaging
modality. In cases of high likelihood of contrast nephropathy,
MRI was used for surveillance. The follow-up period was
adjusted subject to a patient’s co-morbidities and suitability
for surgical intervention. If the follow-up imaging demonstrat-
ed an increased complexity of the cyst, the case was referred to
the multidisciplinary meeting and the imaging was reviewed
by the uroradiologist. Cyst progression was defined by in-
creased cyst complexity resulting in an upgrade in Bosniak
category. Radiological findings attributable to cyst progres-
sion included progressing nodule enhancement, septal thick-
ening and wall thickening [2].
Patients with Bosniak III and IV cysts were discussed in
clinic and surgical intervention was recommended. Surgical
intervention included partial or total nephrectomy, radiofre-
quency ablation or cryoablation, subject to cyst characteristics
and patient-specific factors. Poor surgical candidates or those
who opted for conservative management were followed up
with serial imaging or were discharged, subject to patient
preference.
Interobserver variability
The interobserver agreement was evaluated by comparing the
Bosniak category reported on the initial scan report at the time
of detection, with the category reported at the multidisciplin-
ary meeting by the specialist uroradiologist. All cysts
discussed at the multidisciplinary meeting (Bosniak ≥II) and
reported using the Bosniak classification were included. The
linear and quadratic-weighted kappa statistics were calculated
to evaluate the rate of agreement.
Results
There were 452 cysts in 415 patients recorded in the database
during the study period. After excluding non-complex cysts
(Bosniak II cysts were included within the interobserver rate
analysis), there were 317 cysts: 161 Bosniak IIF (50.8%), 79
Bosniak III (24.9%) and 77 Bosniak IV cysts (24.3%).
Twenty-nine patients had two cysts, two patients had three
cysts and two patients had five cysts. The mean cyst size
was 3.9 cm at the time of diagnosis (range, 0.3–15.0 cm).
Interobserver variability
There were 257 cysts categorised on the initial radiology re-
port and followed up at a multidisciplinary meeting (Table 1).
The two readers agreed on the classification in 70% of cases
(179/257). Overall, there was a good degree of agreement
between the two independent radiologists for all Bosniak cysts
≥ II, as demonstrated by a linear and quadratic-weighted
kappa statistic of 0.65 (95% confidence interval, 0.58–0.73)
and 0.73 (95% confidence interval, 0.54–0.91), respectively.
The rates of disagreement for each Bosniak classification
were as follows: 47% for II, 20% for IIF, 28% for III and 28%
for IV. Rates of disagreement were significantly higher for
Bosniak II cysts than ≥ IIF cysts (p = 0.01). Bosniak II and
IIF cysts were initially over-categorised on 46% (32/70) and
10% (10/98) of occasions, respectively. These were
downgraded on review by a specialist uroradiologist at the
multidisciplinary meeting.
Overview of complex cysts
Bosniak IIF cysts
There were 161 cysts categorised as Bosniak IIF (mean size,
4.0 cm; range, 0.3–12.7 cm). Of this group, 151 cysts (89%,
139 patients) were followed up with surveillance imaging
over a median follow-up time of 21.2 months (range, 3.0–
133.8 months). The remaining 10 cysts (6.2%, 10 patients)
were discharged immediately from follow-up imaging be-
cause the patients were poor surgical candidates.
Seven cysts (4.6%) progressed after a median follow-up
time of 15.5 months (range, 5.6–35.1 months), 6 of which
progressed to Bosniak III (4.0%) and 1 progressed to
Bosniak IV (0.7%) (Fig. 3) (Table 2). Five of the 7 progressed
cysts were surgically resected, one cyst was treated with
cryoablation without a biopsy and one cyst was suitable for
surveillance and regressed to a Bosniak IIF after 42.4 months.
The malignancy rate of the surgically treated cysts was 60%
(3/5), and all malignant cysts progressed within 16 months.
These were completely resected, low ISUP grade and stage,
and there was no recurrence.
Five cysts (3.3%) regressed after a median follow-up time
of 9.8 months (range, 2.1–18.7 months) (Table 2). Cysts
smaller than 2.0 cm were more likely to regress than larger
cysts (p < 0.01). The remaining 139 cysts (92.1%) remained
stable.
Bosniak III cysts
There were 79 Bosniak III cysts in 71 patients (mean size, 4.37
cm; range, 1.0–11.5 cm). Twenty-four cysts (30.4%) were
resected immediately and five cysts underwent delayed resec-
tion after a period of surveillance. One cyst in a transplanted
kidney (1.3%) was amenable to cryoablation and was treated
without biopsy. The malignancy rate of surgically resected
cysts in this category was 79.3% (23/29), and the malignancy
rate in the delayed surgery group was 100% (5/5).
Fifty-four cysts (68.4%) were initially managed conserva-
tively, 39 of which (72.2%) were followed up under surveil-
lance. Of the cysts that were followed up, 32 cysts (82.1%) did
not progress in complexity or size after median follow-up of
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20.5 months. One cyst (2.6%) progressed in complexity to a
Bosniak IV category and was deemed suitable for surveil-
lance. Four cysts (10.3%) increased in size after a median
follow-up period of 30.1 months and underwent delayed re-
section. One cyst was visualised as two separate Bosniak III
cysts on a follow-up scan, and both were resected after 21.1
months of surveillance. Six cysts regressed (15.4%) with a
median time to regression of 15.8 months (range, 6.6–29.0
months).
The most common reasons for conservative management
included preference for surveillance in 13 cysts, poor surgical
candidates because of co-morbidities in 11 cysts (5 of which
were discharged immediately from follow-up imaging), 12
cysts being suitable for surveillance and 10 cysts which were
stable from previous imaging (Table 3).
Bosniak IV cysts
Seventy-seven Bosniak IV cysts were identified in 77 patients
(mean size, 4.01 cm; range, 1.0–9.9 cm). Forty-three cysts
(55.8%) were resected immediately after MDT discussions,
three cysts (3.9%) were resected after a period of surveillance
and four cysts (5.2%) were treated with radiofrequency abla-
tion without a pre-operative biopsy. The malignancy rate in
the surgically resected group was 84.8% (39/46), and the ma-
lignancy rate of cysts which underwent delayed resection was
66.7% (2/3).
Thirty cysts (39.0%) were managed conservatively, 18 of
which (60%) were followed up. Of the cysts that were follow-
ed up, 10 cysts (55.6%) did not progress in complexity or size
after a median follow-up time of 25.3 months (range, 11.6–
84.2), five cysts (27.8%) increased in size after a median
follow-up period of 35.2 months and three cysts (16.7%)
regressed after a median follow-up time of 18.6 months
(Table 2). Three of the five cysts that were increasing in size
underwent delayed resection, one was treated successfully
with radiofrequency ablation without biopsy and one
remained under surveillance. The most common reasons for
conservative management included 11 cysts being suitable for
surveillance, 13 patients (13 cysts) being poor surgical candi-
dates and 4 cysts lost to follow-up (Table 3).
Analysis of the resected cysts
The rate of surgical intervention for IIF, III and IV cysts was
3.1% (5/161), 36.7% (29/79) and 59.7% (46/77), respectively.
Of the resected cysts, 6.3% (5 cysts) were progressed IIF
cysts, 36.3% (29 cysts) were Bosniak III cysts and 57.5%
(46 cysts) were Bosniak IV cysts. In 53% of cases, a partial
nephrectomy was performed; in the remaining 47%, a total
nephrectomy was performed.
The overall rate of malignancy in surgically resected cysts
was 81.3% (65/80) (Table 4). Of the malignant tumours, his-
topathology confirmed that 73.8%were clear cell, 13.8%were
papillary, 6.2% were multilocular cystic carcinomas and the
remaining were either chromophobe or collecting duct carci-
nomas. The malignancy rate in cysts that were resected after a
delay versus those resected immediately was 76.9% (10/13)
and 82.1% (55/67), respectively, and this was not statistically
significant. Of all malignant tumours, 73.8% were of low
Table 1 Pre- and post-multidisciplinary meeting Bosniak classifications
Bosniak pre-multidisciplinary meeting Bosniak post-multidisciplinary meeting
2 2F 3 4 Total
1 1 (0.4%) 1 (0.4%) 0 0 2 (0.8%)
2 37 (14.4%) 9 (3.5%) 1 (0.39%) 1 (0.39%) 48 (18.7%)
2F 27 (10.5%) 78 (30.4%) 12 (4.7%) 4 (1.6%) 121(47.1%)
3 3 (1.2%) 10 (3.9%) 38 (14.8%) 5 (2.0%) 56 (21.8%)
4 2 (0.8%) 0 2 (0.8%) 26 (10.1%) 30 (11.7%)
Total 70 (27.2%) 98 (38.1%) 53 (20.6%) 36 (14.0%) 257 (100%)
Table 2 Progression and regression rates
Initial category Final category
1 2 2F 3 4 Total
2F 4 (2.6%) 1 (0.7%) 139 (92.1%) 6 (4.0%) 1 (0.7%) 151
3 3 (7.7%) 2 (5.1%) 1 (2.6%) 32 (84.8%) 1 (2.6%) 39
4 2 (11.1%) 0 0 1 (5.6%) 15 (83.3%) 18
Total 9 3 140 39 17 208
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ISUP grade, 93.7% were confined to the kidney (stage pT2b
or less) and 81.0% were less than 7 cm (stage pT1a or pT1b).
The recurrence rate was 1.5% (1/65) after a median follow-up
time of 50.2 months (range, 2.8–93.1 months). The grade and
stage of the tumours were not statistically different between
those who had immediate or delayed surgery.
Discussion
Key findings
Overall, there is a good degree of agreement between radiol-
ogists using the Bosniak classification system; however,
Bosniak II cysts are frequently over-graded. Both the rate of
progression and regression of Bosniak IIF cysts are low (4.6%
and 3.3%, respectively), and malignant cysts progress during
the early surveillance period (within 16 months). Surgically
resected Bosniak III and IV cysts have a high rate of malig-
nancy, but the rate of benign cyst resection is still high
(18.8%). Malignant cysts on histopathology showed low-
grade and early-stage renal cancers.
Study findings in relation to relevant literature
The consensus from the literature is that a surveillance period
is safe and facilitates identification of Bosniak IIF lesions that
require surgical intervention [9]. A definitive surveillance pe-
riod for Bosniak IIF cysts has not been settled upon within the
literature, but a period of up to 4 years has been suggested [1,
6, 9]. Our data suggests that malignant progression and regres-
sion in most cases occur early in the surveillance period and a
shorter surveillance period would be acceptable. Of course,
the possibility of later malignant progression remains, albeit
very small and was not observed in this population.
There is no universally accepted interval period between the
surveillance scans for Bosniak IIF cysts [16]. In our study, the
Bosniak IIF cysts were followed up in accordancewith the local
protocol with serial imaging at 6, 12, 24, 36 and 48 months,
subject to patient factors. A total of 287 follow-up scans were
performed on these cysts, and seven instances of progression
were reported. Although the malignancy rate of progressed IIF
cysts is high, all three of the malignant Bosniak IIF cysts were
early stage and low grade; thus, a greater interval between scans
may be appropriate [17]. One study suggests that a longer in-
terval period permits cysts sufficient time to develop radiolog-
ical features and reduces radiation exposure [18]. The rate of
progression of Bosniak IIF cysts within the literature ranges
from 4.6 to 15.6% [5–7]. In the present study, the progression
rate was low (4.6%) and supports a shorter follow-up period
and a greater interval time between surveillance scans.
The unnecessary resection of benign Bosniak III cysts is a
recognised limitation of the Bosniak classification. Prior to the
introduction of the IIF category, the malignancy rate of Bosniak
III cysts had been reported as low as 31% and 45% [3, 11]. The
addition of the intermediate IIF category has improved the clin-
ical significance of the Bosniak classification, as evidenced by
increased malignancy rates of Bosniak III cysts and decreased
resection rates. Studies have since reported malignancy rates
between 60 and 81.8% [8, 19]. Graumann et al conducted a
meta-analysis of 15 retrospective studies and found that the
malignancy rate was 65.4% [20]. In the present study, we report
a malignancy rate of 79.3% and six resected Bosniak III cysts
Table 3 Indications for conservative management of Bosniak III and IV cysts
Indications for conservative management Bosniak III Bosniak IV Total
SRM suitable for surveillance 12 (15.2%) 11 (14.3%) 23 (14.7%)
Poor surgical candidate 11 (13.9%) 13 (16.9%) 20 (12.8%)
Patient preference 13 (16.5%) 2 (2.6%) 15 (9.6%)
Stable or regressing after reviewing previous imaging 10 (12.7%) 0 (0.0%) 10 (6.4%)
Lost to follow-up 3 (3.4%) 4 (5.2%) 7 (4.5%)
Multiple bilateral cysts 5* (6.3%) 0 (0.0%) 5 (3.2%)
SRM small renal mass
*One patient had a total of 5 cysts bilaterally
Fig. 3 Kaplan-Meier analysis—probability of Bosniak IIF cysts remain-
ing stable
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(20.7%) were benign. The revised Bosniak classification pub-
lished by Silverman (2019) et al aimed at reducing the frequen-
cy of benign cyst resections by incorporating explicit defini-
tions of terms and specific inclusion criteria. It defines the num-
ber of septae, thickness of wall and septae and nodularity for
each category and sets the criteria to increase the specificity of
the classification system [21]. These features were not tested in
the present study, and whether the revised Bosniak classifica-
tion of 2019 improves the specificity of categorisation in
predicting malignancy remains to be seen. We envisage that
adoption of more qualitative and quantitative criteria with ma-
chine learning algorithms would certainly reduce the frequency
of benign cyst resections, improve our ability to follow up these
lesions on active surveillance and increase the malignancy rate
of resected cystic renal masses. Future research is required to
externally validate the 2019 classification.
The ISUP grading system is employed to predict the biolog-
ical aggressiveness of the cancer, and an ISUP grade of 1 or 2
predicts a relatively indolent cancer. Of the resected Bosniak III
and IV cysts, 89.5% and 69.2% were of low ISUP grade, re-
spectively. These findings correlate with a low grade of renal
cell carcinomas in the literature irrespective of Bosniak catego-
ry [13, 14]. Given the relatively indolent nature of themalignant
cysts, survival analysis studies with long-term follow-up would
be useful to identify patient sub-groupswhowould benefit from
surgical intervention or surveillance management, particularly
in the Bosniak III and IV groups. Surgical decision-making in
the management of complex renal cystic disease should also
consider patient-related factors such as age and number of co-
morbidities in addition to the risk of malignancy based on clas-
sifications of structural abnormalities on imaging. Any radio-
logical classification can only predict risk of malignancy and
not biological behaviour of renal cancers.
In our study, there was no correlation between delayed
surgery and higher grade. All cysts that underwent delayed
surgery were of low grade, and the period of observation did
not compromise outcome. A period of observation may help
in selecting progressing cysts, increase the malignancy rate of
resected Bosniak III cysts and reduce the proportion of benign
cyst resections. Further studies are warranted to investigate if a
period of observation would reduce the rate of benign surgery
and not compromise cancer outcomes.
Conclusion
This study further confirms that a good degree of agreement
exists between radiologists in classifying complex renal
masses using the Bosniak classification. The progression rate
of Bosniak IIF cysts is low, but the malignancy rates of
progressed Bosniak IIF cysts and Bosniak III and IV cysts
are high. A very high proportion of histopathologically con-
firmed cancers in complex renal cysts are of low grade and
stage.
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Table 4 Histology of surgically resected cysts
Outcome of operation Bosniak IIF (N = 5) Bosniak III (N = 29) Bosniak IV (N = 46) Total (N = 80)
Clear cell RCC 2 (40%) 14 (48.3%) 32 (69.6%) 48 (60%)
Papillary RCC 0 4 (13.8%) 5 (10.9%) 9 (11.3%)
Multilocular cystic RCC 1 (20%) 3 (10.3%) 0 4 (5.0%)
Chromophobe RCC 0 2 (6.9%) 1 (2.2%) 3 (3.4%)
Collecting duct carcinoma 0 0 1 (2.2%) 1 (1.3%)
Multilocular cystic nephroma 0 1 (3.4%) 0 1 (1.3%)
Oncocytoma 0 0 3 (6.5%) 3 (3.4%)
Mixed epithelial and stromal 0 0 1 (2.2%) 1 (1.3%)
Benign cyst 2 (40%) 5 (17.2%) 3 (6.5%) 10 (12.5%)
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